参考文献/References:
[1] Alexander KP,Newby LK,Cannon CP,et al. Acute coronary care in the elderly,part Ⅰ: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology [J]. Circulation,2007,115(19):2570-2589.
[2] Mangoni AA,Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications[J].Br J Clin Pharmacol,2004,57(1):6-14.
[3] Brieger D,Eagle KA,Goodman SG,et al. Acute coronary syndromes without chest pain,an underdiagnosed and undertreated high-risk group: insights from the global registry of acute coronary events[J]. Chest,2004,126(2):461-469.
[4] Bayer AJ ,Chadha JS,Farag RR,et al. Changing presentation of myocardial infarction with increasing old age[J]. J Am Geriatr Soc,1986,34(4):263-266.
[5] Maggioni AA,Maseri A,Fresco C,et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis[J]. N Engl J Med,1993,329(20):1442-1448.
[6] He L,Guo L,Gao W. Clinical characteristics associated with increased in-hospital mortality in patients with acute myocardial infarction[J]. Cardiovasc Revasc Med,2006,7(2):100-106.
[7] Tegn N,Abdelnoor M,Aaberge L,et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial[J]. Lancet,2016,387(10023):1057-1065.
[8] Gimbel ME,Ten Berg JM. Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome[J]. Neth Heart J,2017,25(7-8):409-415.
[9] Jaguszewski M,Ghadri JR,Diekmann J,et al. Acute coronary syndromes in octogenarians referred for invasive evaluation: treatment profile and outcomes[J]. Clin Res Cardiol,2015,104(1):51-58.
[10] Yeomans N,Lanas A,Labenz J,et al. Efficacy of esomeprazole (20mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin[J]. Am J Gastroenterol,2008,103(10):2465-2473.
[11] Amsterdam EA ,Wenger NK,Brindis RG,et al. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation,2014,130:344-426.
[12] Faustino A ,Mota P,Silva J,et al. Non-ST-elevation acute coronary syndromes in octogenarians:applicability of the GRACE and CRUSADE scores[J]. Rev Port Cardiol,2014,33(10):617-627.
[13] Erlinge D,Gurbel PA,James S,et al. Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients[J]. J Am Coll Cardiol,2013,62(7):577-583.
[14] Roe MT,Armstrong PW,Fox KAA,et al.Prasugrel versus clopidogrel for acute coronary syndromes without revascularization[J]. N Engl J Med,2012,367(14):1297-1309.
[15] Roe MT,Goodman SG,Ohman EM,et al. Elderly patients with acute coronary syndromes managed without revascularizationclinical perspective[J]. Circulation,2013,128(8):823-833.
[16] Yusuf S,Zhao F,Mehta SR,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation[J]. N Engl J Med,2001,345(7):494-502.
[17] Bach RG,Cannon CP,Weintraub WS,et al. The effect of routine,early invasive management on outcome for elderly patients with non-st-segment elevation acute coronary syndromes[J]. Acc Curr J Rev,2004,13(11):53-54.
[18] Wallentin LC. Aspirin (75 mg/d) after an episode of unstable coronary artery disease:Long-term effects on the risk for myocardial infarction,occurrence of severe angina and the need for revascularization[J]. J Am Coll Cardiol,1991,18(7):1587-1593.
[19] Alfonso F. Comments on the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation[J]. Rev Esp Cardiol(Engl Ed),2017,70(12):1039-1045.
[20] Vicent L,Velásquez-Rodríguez J,Valero-Masa MJ,et al. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion[J]. Int J Cardiol,2017,248:46-50.
[21] Choudhury T,West NE,El-Omar M. ST elevation myocardial infarction[J]. Clin Med,2016,16(3):277-282.
[22] Shanmugam VB,Harper R,Meredith I,et al. An overview of PCI in the very elderly [J]. J Geriatr Cardiol,2015,12(2):174.
[23] Serbin MA,Guzauskas GF,Veenstra DL. Clopidogrel-proton pump inhibitor drug-drug interaction and risk of adverse clinical outcomes among pci-treated ami patients:a meta-analysis[J]. J Manag Care Spec Pharm,2016,22(8):939-947.
[24] Steg PG,James SK,Atar D,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)[J]. Euro Heart J ,2012,33(20):2569-619.
[25] Sui YG,Teng SY,Qian J,et al. A retrospective study of an invasive versus conservative strategy in patients aged 80 years with acute ST-segment elevation myocardial infarction[J]. J Int Med Res,2019,47(9) 4431-4441.
[26] Salinas GLA,Fernández MS,Izco MP,et al. Frailty predicts major bleeding within 30 days in elderly patients with acute coronary syndrome[J]. Int J Cardiol,2016,222:590-593.
[27] Little M,Johnstone C. Guidelines for the management of acute coronary syndromes 2006[J]. Med J Aust,2007,184(6):372.
[28] Jolly SS,Shenkman H,Brieger D,et al. Quantitative troponin and death,cardiogenic shock,cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE AMI):insights from the Global Registry of Acute Coronary Events[J]. Heart,2011,97(3):197-202.
[29] Sui YG,Teng ST,Qian J,et al. Invasive versus conservative strategy in consecutive patients aged 80 years or older with non-ST-elevation myocardial infarction:a retrospective study in China[J]. J Geriatric Cardiology,2019,16(10):741-748.
[30] Sinclair H,Kunadian V. Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes[J]. Heart,2016,102(6):416-424.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(4):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(4):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(4):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(4):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(4):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(4):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(4):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(4):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(4):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]